Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy

被引:45
|
作者
Odze, R. D. [1 ]
Lauwers, G. Y. [2 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1055/s-0028-1103416
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This review focuses on the histopathological evaluation of endoscopic mucosal resection (EMR) specimens in Barrett's esophagus, and on the histopathological, biological, and molecular properties of postablation Barrett's esophagus. EMR may be used for both diagnostic and therapeutic purposes. Diagnostic accuracy regarding the grade and stage of neoplasms is improved with the use of EMR, but the value of this technique for treatment is more controversial because of the high prevalence rate of positive margins and the rate of metachronous lesions found elsewhere in the esophagus during follow-up. Ablation techniques, such as argon plasma coagulation, photodynamic therapy, and radiofrequency ablation, are used increasingly for the treatment of Barrett's esophagus and related neoplasms, often in combination with EMR. A common problem after use of these techniques is the development of islands of neosquamous epithelium (NSE) which can overlie buried Barrett's (and/or dysplasia) epithelium. This is, therefore, concealed to the endoscopist's view and may be allowed to progress to cancer without detection. NSE is histologically similar to normal esophageal squamous epithelium and does not possess the molecular aberrations characteristic of Barrett's esophagus. In contrast, residual nonburied Barrett's esophagus shows persistent pathologic and molecular abnormalities and may progress to cancer upon long term followup. The biological potential and rate of progression of nonburied residual Barrett's esophagus following ablation is unclear, but some preliminary studies suggest that the risk may decrease. Buried nondysplastic Barrett's esophagus appears to show decreased biological potential and this may be related to protection from the contents of the lumen by the barrier function of the overlying NSE. On the other hand, anecdotal reports have suggested that buried dysplasia may progress to cancer in some instances. © Georg Thieme Verlag KG Stuttgart.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 50 条
  • [21] Endoscopic Mucosal Resection of Barrett’s Esophagus and Early Esophageal Cancer
    Jeffrey H. Peters
    Thomas A. Watson
    Journal of Gastrointestinal Surgery, 2011, 15
  • [22] Endoscopic mucosal resection (EMR) for intramucosal neoplasia in Barrett's esophagus
    Bergman, JJ
    Fockens, P
    Van Lanschot, JJB
    Ten Kate, FJW
    Van Deventer, S
    Tytgat, GNJ
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB206 - AB206
  • [23] Endoscopic mucosal resection in barrett's esophagus: Predictors of success and complications
    Wang, K.
    WongKeeSong, M.
    Buttar, N.
    Prasad, G.
    Borkenhagen, L.
    Lutzke, L.
    ANNALS OF ONCOLOGY, 2007, 18 : VII91 - VII91
  • [24] Endoscopic Ablation of Early Cancer in Barrett's Esophagus: Long-Term Results of Mucosal Resection Followed By Photodynamic Therapy
    Haringsma, Jelle
    Van Heel, Nicoline C.
    Kuipers, Ernst J.
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB345 - AB345
  • [25] Safety and Efficacy of Endoscopic Mucosal Therapy With Radiofrequency Ablation for Patients With Neoplastic Barrett's Esophagus
    Bulsiewicz, William J.
    Kim, Hannah P.
    Dellon, Evan S.
    Cotton, Cary C.
    Pasricha, Sarina
    Madanick, Ryan D.
    Spacek, Melissa B.
    Bream, Susan E.
    Chen, Xiaoxin
    Orlando, Roy C.
    Shaheen, Nicholas J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 636 - 642
  • [26] Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus
    Buttar, NS
    Wang, KK
    Lutzke, LS
    Krishnadath, KK
    Anderson, MA
    GASTROINTESTINAL ENDOSCOPY, 2001, 54 (06) : 682 - 688
  • [27] Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus
    Dunbar, Kerry B.
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 446 - 453
  • [28] Endoscopic mucosal or submucosal resection of early neoplasia in Barrett's esophagus after antireflux surgery
    Van den Eynde, Marc
    Jouret-Mourin, Anne
    Sempoux, Christine
    Piessevaux, Hubert
    Deprez, Pierre H.
    GASTROINTESTINAL ENDOSCOPY, 2010, 72 (04) : 855 - 861
  • [29] Findings at esophagectomy after endoscopic mucosal resection (EMR) of neoplastic lesions in Barrett's esophagus
    Wang, K
    Prasad, G
    Buttar, N
    Song, MWK
    Lewis, J
    Lutze, L
    Borkenhagen, L
    GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB94 - AB94
  • [30] When to consider endoscopic ablation therapy for Barrett's esophagus
    Shaheen, Nicholas J.
    Frantz, David J.
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (04) : 361 - 366